Shandong Sito Bio-Technology Co.Ltd(300583) : independent opinions of independent directors on matters related to the seventh meeting of the third board of directors

Shandong Sito Bio-Technology Co.Ltd(300583)

Opinions of independent directors on matters related to the seventh meeting of the third board of directors

separate opinion

In accordance with the company law of the people’s Republic of China, the rules for independent directors of listed companies, the self regulatory guidelines for companies listed on the gem of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem and other laws and regulations, normative documents, the articles of association, the working rules for independent directors and other rules and regulations, Mr. Zhang Qiming, Mr. Tu Pengfei, the independent directors of Shandong Sito Bio-Technology Co.Ltd(300583) (hereinafter referred to as “the company”) After carefully reviewing the relevant materials provided by the board of directors of the company, and based on his own independent judgment, Mr. Qing Beijun expressed his independent opinions on the proposal on terminating the issuance of A-Shares to specific objects in 2021 and withdrawing the application documents at the seventh meeting of the third board of directors as follows:

All independent directors believe that the company’s decision to terminate the issue of A-Shares to specific objects in 2021 and withdraw the application documents is a decision made by the company after careful analysis, taking into account the changes in the current capital market environment and financing opportunities, combined with the actual situation of the company, future development planning and other factors. At present, all businesses of the company operate normally. The withdrawal of relevant application documents will not have a significant impact on the daily production and operation of the company, and there is no situation that damages the interests of the company and all shareholders, especially minority shareholders. The deliberation procedures of the board of directors of the company on this matter comply with the provisions of relevant laws and regulations, normative documents and the articles of association, such as the company law, the Shenzhen Stock Exchange GEM Listing Rules, the Shenzhen Stock Exchange GEM listed companies self regulatory guidance No. 1 – business handling. Therefore, we unanimously agree that the company will terminate the issue of A-Shares to specific objects in 2021 and withdraw the application documents.

Independent director: Zhang Qiming, Tu Pengfei, Qing Beijun

April 6, 2002

- Advertisment -